AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Bone TransplantationBone and BonesClinical Trials as TopicBone RemodelingBone DensityKidney TransplantationBone ResorptionBone MarrowTreatment OutcomeBone Marrow TransplantationTransplantsBone Marrow CellsBone NeoplasmsBone DevelopmentGraft RejectionBone DiseasesClinical Trials, Phase III as TopicImmunosuppressive AgentsGraft SurvivalTransplantation, HomologousTime FactorsClinical Trials, Phase II as TopicHeart TransplantationClinical Trials, Phase I as TopicBone RegenerationResearch DesignTissue DonorsDouble-Blind MethodTransplantationBone MatrixControlled Clinical Trials as TopicLung TransplantationFollow-Up StudiesPatient SelectionProspective StudiesRetrospective StudiesFractures, BoneBone Diseases, MetabolicBone SubstitutesPostoperative ComplicationsRandomized Controlled Trials as TopicCyclosporineTissue and Organ ProcurementHematopoietic Stem Cell TransplantationTacrolimusRisk FactorsBone Morphogenetic ProteinsImmunosuppressionMulticenter Studies as TopicNeoplasmsDrug Therapy, CombinationSurvival AnalysisPlacebosLiving DonorsWaiting ListsRecurrenceClinical ProtocolsBone Morphogenetic Protein 2Transplantation, AutologousOsteogenesisClinical Trials Data Monitoring CommitteesAntineoplastic AgentsSurvival RateClinical Trials, Phase IV as TopicTemporal BoneCytomegalovirus InfectionsDrug Administration ScheduleFetal Tissue TransplantationMycophenolic AcidGraft vs Host DiseaseCombined Modality TherapyKidney Failure, ChronicCadaverHistocompatibility TestingPrognosisUnited StatesSingle-Blind MethodFemurBiological MarkersParietal BonePilot ProjectsImmunocompromised HostTransplantation ImmunologyOsteoporosisQuality of LifeDose-Response Relationship, DrugEarly Termination of Clinical Trials